SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-090111
Filing Date
2004-05-17
Accepted
2004-05-17 16:51:32
Documents
4
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT d10q.htm 10-Q 277843
2 SECTION 302 CERTIFICATION OF THE CEO dex311.htm EX-31.1 8355
3 SECTION 302 CERTIFICATION OF THE CFO dex312.htm EX-31.2 8389
4 SECTION 906 CERTIFICATION OF THE CEO & CFO dex32.htm EX-32 5161
  Complete submission text file 0001193125-04-090111.txt   301555
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 04813174
SIC: 2836 Biological Products, (No Diagnostic Substances)